4/24/2013

Policies that result in higher generic drug utilization rates would save the U.S. government $49 billion over a decade, according to the Bipartisan Policy Center's Health Care Cost Containment Initiative.

Full Story:
PharmaTimes (U.K.)

Related Summaries